206 related articles for article (PubMed ID: 37238701)
1. Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome.
He J; Pham TL; Kakazu AH; Ponnath A; Do KV; Bazan HEP
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238701
[TBL] [Abstract][Full Text] [Related]
2. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
3. Luteolin ameliorates cornea stromal collagen degradation and inflammatory damage in rats with corneal alkali burn.
Wang H; Guo Z; Liu P; Yang X; Li Y; Lin Y; Zhao X; Liu Y
Exp Eye Res; 2023 Jun; 231():109466. PubMed ID: 37059215
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
5. The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor.
Chen L; Zhong J; Li S; Li W; Wang B; Deng Y; Yuan J
Drug Des Devel Ther; 2018; 12():2959-2969. PubMed ID: 30254425
[TBL] [Abstract][Full Text] [Related]
6. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.
Uchiyama M; Shimizu A; Masuda Y; Nagasaka S; Fukuda Y; Takahashi H
Mol Vis; 2013; 19():2135-50. PubMed ID: 24194635
[TBL] [Abstract][Full Text] [Related]
7. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.
Li Q; Hua X; Li L; Zhou X; Tian Y; Deng Y; Zhang M; Yuan X; Chi W
Cell Commun Signal; 2022 May; 20(1):59. PubMed ID: 35524333
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn.
Li J; Han J; Shi Y; Liu M
Exp Eye Res; 2023 Aug; 233():109539. PubMed ID: 37315833
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
10. Characterization of C-X-C chemokine receptor type 5 in the cornea and role in the inflammatory response after corneal injury.
Balne PK; Gupta S; Landon KM; Sinha NR; Hofmann AC; Hauser N; Sinha PR; Huang H; Kempuraj D; Mohan RR
Exp Eye Res; 2023 Jan; 226():109312. PubMed ID: 36400287
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of a novel venom abstract (ZK002) solution in an alkali-burned corneal wound-healing model.
Peng WY; Wang F; Yang SJ; Sun QY; Zhou HS; Li X; Jiang ZX; Zhou SY
Mol Vis; 2023; 29():317-328. PubMed ID: 38264612
[TBL] [Abstract][Full Text] [Related]
12.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
13. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury.
Sotozono C; He J; Tei M; Honma Y; Kinoshita S
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2430-4. PubMed ID: 10476814
[TBL] [Abstract][Full Text] [Related]
14. Olopatadine enhances recovery of alkali-induced corneal injury in rats.
Kandeel S; Balaha M
Life Sci; 2018 Aug; 207():499-507. PubMed ID: 30056863
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface.
Cejkova J; Trosan P; Cejka C; Lencova A; Zajicova A; Javorkova E; Kubinova S; Sykova E; Holan V
Exp Eye Res; 2013 Nov; 116():312-23. PubMed ID: 24145108
[TBL] [Abstract][Full Text] [Related]
16. Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.
Cejkova J; Cejka C; Trosan P; Zajicova A; Sykova E; Holan V
Exp Eye Res; 2016 Jun; 147():128-137. PubMed ID: 27181227
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
18. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts.
Lee SH; Kim KW; Joo K; Kim JC
BMC Ophthalmol; 2016 May; 16():57. PubMed ID: 27356868
[TBL] [Abstract][Full Text] [Related]
19. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
Yamada J; Dana MR; Sotozono C; Kinoshita S
Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
[TBL] [Abstract][Full Text] [Related]
20. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
